Back to MACKENZIE FINANCIAL CORP MACKENZIE FINANCIAL CORP

NKTRNKTR
Showing 4 of 16 quarters

Position history for MACKENZIE FINANCIAL CORPMACKENZIE FINANCIAL CORP's holdings in Nektar Therapeutics

MACKENZIE FINANCIAL CORP previously held 0 shares of NKTR (Nektar Therapeutics), worth $0 as of 2025-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$67,753

Total Shares Change

-52,118

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$25.76
0
2025-Q1
Increased
1.7M
+17.7%
$1.1M0.0%$11.10
29
2024-Q4
Increased
1.4M
+2604.1%
$1.3M0.0%$14.10
41
2024-Q3
Increased
52,118
+19.1%
$67,7530.0%$17.55
25

Other major holders of NKTR: BNP PARIBAS FINANCIAL MARKETS, Invesco Ltd., PRIMECAP MANAGEMENT CO/CA/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used